Paper401808
Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.
Helting TB and 1 other. J Biol Chem, 1977. Cited by 141 papers, by iCite.
Cite this record
ConductScience Library. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments. Papers, record 401808. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/401808
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tetanus Toxin | Major topic |
| Amino Acids | |
| Animals | |
| Biological Assay | |
| Immune Sera | |
| Immunodiffusion | |
| Macromolecular Substances | |
| Mice | |
| Molecular Weight | |
| Papain | |
| Peptide Fragments |
Source PubMed
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37663798 | Phage display technology for fabricating a recombinant monoclonal ScFv antibody against tetanus toxin. | Toxicol Res (Camb) | 2023 | https://conductscience.org/library/papers/37663798 | PubMed |
| 35745675 | Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35745675 | PubMed |
| 34680132 | Confocal Endomicroscopy of Neuromuscular Junctions Stained with Physiologically Inert Protein Fragments of Tetanus Toxin. | Biomolecules | 2021 | https://conductscience.org/library/papers/34680132 | PubMed |
| 31721050 | Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization. | Neurotox Res | 2020 | https://conductscience.org/library/papers/31721050 | PubMed |
| 30240216 | Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins. | Mol Pharm | 2018 | https://conductscience.org/library/papers/30240216 | PubMed |
| 27626445 | Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library. | Toxins (Basel) | 2016 | https://conductscience.org/library/papers/27626445 | PubMed |
| 27348002 | Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys. | Toxins (Basel) | 2016 | https://conductscience.org/library/papers/27348002 | PubMed |
| 25868452 | Engineered nanoparticles mimicking cell membranes for toxin neutralization. | Adv Drug Deliv Rev | 2015 | https://conductscience.org/library/papers/25868452 | PubMed |
| 24678405 | Recombinant human antibody fragment against tetanus toxoid produced by phage display. | Eur J Microbiol Immunol (Bp) | 2014 | https://conductscience.org/library/papers/24678405 | PubMed |
| 24395625 | Molecular imaging detects impairment in the retrograde axonal transport mechanism after radiation-induced spinal cord injury. | Mol Imaging Biol | 2014 | https://conductscience.org/library/papers/24395625 | PubMed |
| 23949787 | Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates. | Glycoconj J | 2013 | https://conductscience.org/library/papers/23949787 | PubMed |
| 19757026 | Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant. | Glycoconj J | 2010 | https://conductscience.org/library/papers/19757026 | PubMed |
| 19730859 | Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression. | Cancer Immunol Immunother | 2010 | https://conductscience.org/library/papers/19730859 | PubMed |
| 16785105 | Re-engineering the target specificity of Clostridial neurotoxins - a route to novel therapeutics. | Neurotox Res | 2006 | https://conductscience.org/library/papers/16785105 | PubMed |
| 14675488 | Emerging Applications of Bacterial Spores in Nanobiotechnology. | J Nanobiotechnology | 2003 | https://conductscience.org/library/papers/14675488 | PubMed |
| 11591673 | Surface display of recombinant proteins on Bacillus subtilis spores. | J Bacteriol | 2001 | https://conductscience.org/library/papers/11591673 | PubMed |
| 10992478 | Protective antigen-mediated antibody response against a heterologous protein produced in vivo by Bacillus anthracis. | Infect Immun | 2000 | https://conductscience.org/library/papers/10992478 | PubMed |
| 10456940 | Cell surface-exposed tetanus toxin fragment C produced by recombinant Bacillus anthracis protects against tetanus toxin. | Infect Immun | 1999 | https://conductscience.org/library/papers/10456940 | PubMed |
| 9529093 | A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. | Infect Immun | 1998 | https://conductscience.org/library/papers/9529093 | PubMed |
| 8757849 | Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin. | Infect Immun | 1996 | https://conductscience.org/library/papers/8757849 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/401808
GET https://conductscience.org/api/papers/v1/401808/cited_by?page=2